Petmedix joins NOAH Association

The UK’s animal health business is recognised and supported by NOAH. Its objective is to raise awareness around the advantages of approved treatments and measures for the health and well-being of every species of animal.

PetMedix, a new associate member of NOAH, is a Cambridge based firm focused on the study and production of monoclonal antibodies for companion animals

“We are delighted to welcome PetMedix to NOAH and look forward to working with them,” stated the Chief Executive of Noah, Dawn Howard. “Their cutting-edge work highlights how our sector can contribute to the scientific excellence of the UK, and shows One Health in action, building on human medical research to bring exciting treatment potentials to our pets.”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.